Literature DB >> 11722641

Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection.

U Seitzer1, K Kayser, H Höhn, P Entzian, H H Wacker, S Ploetz, H D Flad, J Gerdes, M J Maeurer.   

Abstract

Control of mycobacterial infection by the cellular immune system relies both on antigen-presenting cells and on T lymphocytes. The quality of an effective cellular immune response is dependent on functional signal transduction residing in the cytoplasmic tails of the T-cell receptor CD3 components. In order to investigate potential effects of mycobacteria on T-cell receptor signalling, we examined the protein expression of T-cell signal transduction molecules (CD3zeta, ZAP-70, p59fyn, p56lck). In Western blots of peripheral blood mononuclear cells of Mycobacterium tuberculosis infected patients, only the CD3zeta-chain showed a marked reduction in protein expression. To investigate the situation in situ, immunoenzymatic and immunofluorescence stainings for CD3epsilon and CD3zeta expression were performed on sections of normal lymphoid tissue, M. leprae infected and sarcoid tissue. CD3epsilon and CD3zeta expression were similar with respect to intensity, localization and the number of cells stained in normal lymphoid tissue and in sarcoid granulomas. In contrast, the granulomas of M. leprae infected tissues showed a significantly reduced expression of CD3zeta compared to CD3epsilon. Using double immunofluorescence analysis, virtually no CD3zeta expression could be detected in comparison to the CD3epsilon expression in the lesions. Apparently, mycobacteria are capable of significantly reducing CD3zeta-chain expression, which may be restored by cytokines. IL-2-enhanced zeta-chain expression and T-cell effector functions, defined by interferon-gamma release, in M. tuberculosis-specific and human leucocyte antigen-DR restricted CD4+ T cells isolated from granuloma lesions from patients with pulmonary tuberculosis. Because CD3zeta is essential for CD3 signalling and for eliciting T-cell effector functions, reduced CD3zeta protein expression could result in altered signal transduction and inefficient T-cell effector functions. Alternatively, reduced CD3zeta-chain expression may protect T cells from repetitive TCR stimulation associated with anergy or apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722641      PMCID: PMC1783312          DOI: 10.1046/j.1365-2567.2001.01323.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

Review 1.  The Koch phenomenon and the immunopathology of tuberculosis.

Authors:  G A Rook; J L Stanford
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

2.  T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.

Authors:  C Renner; S Ohnesorge; G Held; S Bauer; W Jung; J P Pfitzenmeier; M Pfreundschuh
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

3.  IL-15, an immunomodulator of T cell responses in intracellular infection.

Authors:  D Jullien; P A Sieling; K Uyemura; N D Mar; T H Rea; R L Modlin
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

4.  Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules.

Authors:  A Guarini; L Riera; A Cignetti; L Montacchini; M Massaia; R Foa
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

5.  IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses.

Authors:  T K VanHeyningen; H L Collins; D G Russell
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

6.  CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family.

Authors:  E M Beckman; A Melián; S M Behar; P A Sieling; D Chatterjee; S T Furlong; R Matsumoto; J P Rosat; R L Modlin; S A Porcelli
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

7.  Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity.

Authors:  K Kono; F Salazar-Onfray; M Petersson; J Hansson; G Masucci; K Wasserman; T Nakazawa; P Anderson; R Kiessling
Journal:  Eur J Immunol       Date:  1996-06       Impact factor: 5.532

8.  Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions.

Authors:  E Richter; U Greinert; D Kirsten; S Rüsch-Gerdes; C Schlüter; M Duchrow; J Galle; H Magnussen; M Schlaak; H D Flad; J Gerdes
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

9.  Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.

Authors:  K F Yoong; D H Adams
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells.

Authors:  Z Cai; H Kishimoto; A Brunmark; M R Jackson; P A Peterson; J Sprent
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  10 in total

1.  Human leukocyte antigens A*3001 and A*3002 show distinct peptide-binding patterns of the Mycobacterium tuberculosis protein TB10.4: consequences for immune recognition.

Authors:  Rebecca Axelsson-Robertson; Raija K Ahmed; Frank F Weichold; Marthie M Ehlers; Marleen M Kock; Donata Sizemore; Jerry Sadoff; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

2.  Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.

Authors:  Rebecca Axelsson-Robertson; Frank Weichold; Donata Sizemore; Markus Wulf; Yasir A W Skeiky; Jerry Sadoff; Markus J Maeurer
Journal:  Immunology       Date:  2009-11-25       Impact factor: 7.397

3.  T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome.

Authors:  Diego H Aviles; Matti V Vehaskari; Kirk S Culotta; Jennifer Manning; Augusto C Ochoa; Arnold H Zea
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

4.  Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401.

Authors:  Simani Gaseitsiwe; Davide Valentini; Shahnaz Mahdavifar; Marie Reilly; Anneka Ehrnst; Markus Maeurer
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

5.  Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T-cell activation by interfering with proximal T-cell-receptor signaling.

Authors:  Robert N Mahon; Roxana E Rojas; Scott A Fulton; Jennifer L Franko; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

6.  Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell subpopulation.

Authors:  H Höhn; M Jülch; H Pilch; C Kortsik; G Tully; C Neukirch; K Freitag; M Maeurer
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

7.  The risk factors for tuberculosis in liver or kidney transplant recipients.

Authors:  Jia Liu; Jin Yan; Qiquan Wan; Qifa Ye; Yisheng Huang
Journal:  BMC Infect Dis       Date:  2014-07-11       Impact factor: 3.090

8.  Temporal Expression of Peripheral Blood Leukocyte Biomarkers in a Macaca fascicularis Infection Model of Tuberculosis; Comparison with Human Datasets and Analysis with Parametric/Non-parametric Tools for Improved Diagnostic Biomarker Identification.

Authors:  Sajid Javed; Leanne Marsay; Alice Wareham; Kuiama S Lewandowski; Ann Williams; Michael J Dennis; Sally Sharpe; Richard Vipond; Nigel Silman; Graham Ball; Karen E Kempsell
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

9.  Mycobacterium tuberculosis secretory proteins downregulate T cell activation by interfering with proximal and downstream T cell signalling events.

Authors:  Bhawna Sharma; Rajni Upadhyay; Bhavyata Dua; Naim Akhtar Khan; Vishwa Mohan Katoch; Bharat Bajaj; Beenu Joshi
Journal:  BMC Immunol       Date:  2015-11-09       Impact factor: 3.615

10.  T Cell Interactions in Mycobacterial Granulomas: Non-Specific T Cells Regulate Mycobacteria-Specific T Cells in Granulomatous Lesions.

Authors:  Dominic O Co; Laura H Hogan; Jozsef Karman; Melinda Herbath; Zsuzsanna Fabry; Matyas Sandor
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.